anmelden
OMX Stockholm 30
3.292,34
PKT
+34,01
PKT
+1,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Stockholm 30-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 29.03.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | JP Morgan Chase & Co. | |
| 29.03.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | BNP PARIBAS | |
| 29.03.17 | Ericsson (Telefon L.M.Ericsson) (B) buy | Goldman Sachs Group Inc. | |
| 29.03.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 29.03.17 | Ericsson (Telefon L.M.Ericsson) (B) Hold | S&P Capital IQ | |
| 28.03.17 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 23.03.17 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
| 23.03.17 | AstraZeneca buy | Société Générale Group S.A. (SG) | |
| 23.03.17 | Volvo (B) buy | HSBC | |
| 21.03.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 20.03.17 | AstraZeneca buy | Deutsche Bank AG | |
| 20.03.17 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.03.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 16.03.17 | ABB (Asea Brown Boveri) Outperform | Robert W. Baird & Co. Incorporated | |
| 15.03.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 15.03.17 | AstraZeneca buy | Deutsche Bank AG | |
| 13.03.17 | Ericsson (Telefon L.M.Ericsson) (B) buy | Goldman Sachs Group Inc. | |
| 13.03.17 | Volvo (B) buy | UBS AG | |
| 10.03.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | UBS AG | |
| 09.03.17 | AstraZeneca buy | Jefferies & Company Inc. | |
| 09.03.17 | Ericsson (Telefon L.M.Ericsson) (B) buy | Goldman Sachs Group Inc. | |
| 08.03.17 | AstraZeneca overweight | Barclays Capital | |
| 07.03.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | UBS AG | |
| 06.03.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 28.02.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 23.02.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 22.02.17 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
| 22.02.17 | Ericsson (Telefon L.M.Ericsson) (B) Equal-Weight | Morgan Stanley | |
| 21.02.17 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.02.17 | ABB (Asea Brown Boveri) Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.02.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 17.02.17 | AstraZeneca buy | Jefferies & Company Inc. | |
| 17.02.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 16.02.17 | Ericsson (Telefon L.M.Ericsson) (B) Sell | Goldman Sachs Group Inc. | |
| 10.02.17 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 09.02.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | UBS AG | |
| 09.02.17 | ABB (Asea Brown Boveri) Sell | Citigroup Corp. | |
| 09.02.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 09.02.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 09.02.17 | ABB (Asea Brown Boveri) overweight | Morgan Stanley |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.
